Alamar Launches New Alzheimer's Biomarker Detection Assay
January 13, 2026 | 14:38
The biotechnology company introduces its blood-based testing solution for Alzheimer's disease research, offering researchers an advanced tool to detect multiple biomarkers simultaneously through the NULISAqpcr platform.
Mobile Version